118 related articles for article (PubMed ID: 26437123)
1. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
Knopman DS; Jack CR; Lundt ES; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
JAMA Neurol; 2015 Dec; 72(12):1475-83. PubMed ID: 26437123
[TBL] [Abstract][Full Text] [Related]
2. Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum.
Knopman DS; Jack CR; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
Neurobiol Aging; 2016 Oct; 46():32-42. PubMed ID: 27460147
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.
Lao PJ; Handen BL; Betthauser TJ; Mihaila I; Hartley SL; Cohen AD; Tudorascu DL; Bulova PD; Lopresti BJ; Tumuluru RV; Murali D; Mathis CA; Barnhart TE; Stone CK; Price JC; Devenny DA; Johnson SC; Klunk WE; Christian BT
J Alzheimers Dis; 2018; 61(2):631-644. PubMed ID: 29254096
[TBL] [Abstract][Full Text] [Related]
4. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
Shirzadi Z; Schultz SA; Yau WW; Joseph-Mathurin N; Fitzpatrick CD; Levin R; Kantarci K; Preboske GM; Jack CR; Farlow MR; Hassenstab J; Jucker M; Morris JC; Xiong C; Karch CM; Levey AI; Gordon BA; Schofield PR; Salloway SP; Perrin RJ; McDade E; Levin J; Cruchaga C; Allegri RF; Fox NC; Goate A; Day GS; Koeppe R; Chui HC; Berman S; Mori H; Sanchez-Valle R; Lee JH; Rosa-Neto P; Ruthirakuhan M; Wu CY; Swardfager W; Benzinger TLS; Sohrabi HR; Martins RN; Bateman RJ; Johnson KA; Sperling RA; Greenberg SM; Schultz AP; Chhatwal JP;
JAMA Neurol; 2023 Dec; 80(12):1353-1363. PubMed ID: 37843849
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Glucose Metabolism in [
Lee JJ; Earnest T; Ha SM; Bani A; Kothapalli D; Liu P; Sotiras A
medRxiv; 2023 Nov; ():. PubMed ID: 38116031
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of Aging.
Wennberg AMV; Savica R; Hagen CE; Roberts RO; Knopman DS; Hollman JH; Vemuri P; Jack CR; Petersen RC; Mielke MM
J Am Geriatr Soc; 2017 Apr; 65(4):792-799. PubMed ID: 27869301
[TBL] [Abstract][Full Text] [Related]
7. Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort.
Gallet Q; Bouteloup V; Locatelli M; Habert MO; Chupin M; Campion JY; Michels PE; Delrieu J; Lebouvier T; Balageas AC; Surget A; Belzung C; Arlicot N; Ribeiro MS; Gissot V; El-Hage W; Camus V; Gohier B; Desmidt T;
Am J Geriatr Psychiatry; 2024 Jun; 32(6):665-677. PubMed ID: 37973486
[TBL] [Abstract][Full Text] [Related]
8. Cortical Microstructural Alterations in Mild Cognitive Impairment and Alzheimer's Disease Dementia.
Vogt NM; Hunt JF; Adluru N; Dean DC; Johnson SC; Asthana S; Yu JJ; Alexander AL; Bendlin BB
Cereb Cortex; 2020 May; 30(5):2948-2960. PubMed ID: 31833550
[TBL] [Abstract][Full Text] [Related]
9. Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative.
Madsen SK; Rajagopalan P; Joshi SH; Toga AW; Thompson PM;
Neurobiol Aging; 2015 Jan; 36 Suppl 1():S203-10. PubMed ID: 25444607
[TBL] [Abstract][Full Text] [Related]
10. Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease.
Raghavan NS; Dumitrescu L; Mormino E; Mahoney ER; Lee AJ; Gao Y; Bilgel M; Goldstein D; Harrison T; Engelman CD; Saykin AJ; Whelan CD; Liu JZ; Jagust W; Albert M; Johnson SC; Yang HS; Johnson K; Aisen P; Resnick SM; Sperling R; De Jager PL; Schneider J; Bennett DA; Schrag M; Vardarajan B; Hohman TJ; Mayeux R;
JAMA Neurol; 2020 Oct; 77(10):1288-1298. PubMed ID: 32568366
[TBL] [Abstract][Full Text] [Related]
11. A graph theoretic approach to neurodegeneration: five data-driven neuropsychological subtypes in mild cognitive impairment.
Pommy J; Conant L; Butts AM; Nencka A; Wang Y; Franczak M; Glass-Umfleet L
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2023; 30(6):903-922. PubMed ID: 36648118
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Neuroimaging and Cognition in Frontotemporal Dementia: A [18 F]FDG PET and Structural MRI Study.
Cayir S; Volpi T; Toyonaga T; Gallezot JD; Yanghong Y; Sadabad FE; Mulnix T; Mecca AP; Fesharaki-Zadeh A; Matuskey D
Res Sq; 2024 Jan; ():. PubMed ID: 38313264
[TBL] [Abstract][Full Text] [Related]
13. A multimodal clinical diagnostic approach using MRI and
Lavrova A; Pham NTT; Vernon CJ; Carlos AF; Petersen RC; Dickson DW; Lowe VJ; Jack CR; Whitwell JL; Josephs KA
J Neurol; 2024 Apr; ():. PubMed ID: 38578498
[TBL] [Abstract][Full Text] [Related]
14. Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with
Chiang GC; Mao X; Kang G; Chang E; Pandya S; Vallabhajosula S; Isaacson R; Ravdin LD; ; Shungu DC
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1130-1137. PubMed ID: 28341718
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Alzheimer's Disease Imaging Biomarkers in World Trade Center Responders with Cognitive Impairment at Midlife.
Kritikos M; Franceschi AM; Vaska P; Clouston SAP; Huang C; Salerno M; Deri Y; Tang C; Pellecchia A; Santiago-Michels S; Sano M; Bromet EJ; Lucchini RG; Gandy S; Luft BJ
World J Nucl Med; 2022 Dec; 21(4):267-275. PubMed ID: 36398306
[No Abstract] [Full Text] [Related]
16. Correlations between sleep disturbance and brain structures associated with neurodegeneration in the National Alzheimer's Coordinating Center Uniform Data Set.
Burke S; Grudzien A; Li T; Abril M; Spadola C; Barnes C; Hanson K; Grandner M; DeKosky S
J Clin Neurosci; 2022 Dec; 106():204-212. PubMed ID: 35970678
[TBL] [Abstract][Full Text] [Related]
17. Atrophy, hypometabolism and implication regarding pathology in late-life major depression with suspected non-alzheimer pathophysiology (SNAP).
Wu KY; Lin KJ; Chen CH; Liu CY; Wu YM; Yen TC; Hsiao IT
Biomed J; 2023 Dec; 46(6):100589. PubMed ID: 36914051
[TBL] [Abstract][Full Text] [Related]
18. Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression.
Caroli A; Prestia A; Galluzzi S; Ferrari C; van der Flier WM; Ossenkoppele R; Van Berckel B; Barkhof F; Teunissen C; Wall AE; Carter SF; Schöll M; Choo IH; Grimmer T; Redolfi A; Nordberg A; Scheltens P; Drzezga A; Frisoni GB;
Neurology; 2015 Feb; 84(5):508-15. PubMed ID: 25568301
[TBL] [Abstract][Full Text] [Related]
19. Energetic Cost of Walking and Brain Atrophy in Mid-to-Late Life.
Dougherty RJ; Liu F; An Y; Wanigatunga AA; Tian Q; Davatzikos C; Simonsick EM; Ferrucci L; Resnick SM; Schrack JA
J Gerontol A Biol Sci Med Sci; 2022 Oct; 77(10):2068-2076. PubMed ID: 34628503
[TBL] [Abstract][Full Text] [Related]
20. History of traumatic brain injury is associated with increased grey-matter loss in patients with mild cognitive impairment.
Khoury MA; Churchill NW; Di Battista A; Graham SJ; Symons S; Troyer AK; Roberts A; Kumar S; Tan B; Arnott SR; Ramirez J; Tartaglia MC; Borrie M; Pollock B; Rajji TK; Pasternak SH; Frank A; Tang-Wai DF; Scott CJM; Haddad SMH; Nanayakkara N; Orange JB; Peltsch A; Fischer CE; Munoz DG; Schweizer TA
J Neurol; 2024 May; ():. PubMed ID: 38717612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
